COVID-19 Vaccines Show Waning Protection But Strong Critical Illness Prevention

This large-scale study analyzed the real-world effectiveness of 2023-2024 COVID-19 vaccines during a period when SARS-CoV-2 variants XBB and JN.1 dominated circulation. The research matters because it provides crucial data on how well updated vaccines perform against evolving viral strains and informs ongoing vaccination strategies.

Researchers used a test-negative case-control design across six US healthcare systems, examining 345,955 emergency department and urgent care encounters plus 111,931 hospitalizations from September 2023 to August 2024. They compared vaccination rates between patients who tested positive versus negative for COVID-19 while controlling for various factors.

Key results showed modest but meaningful protection: 29% vaccine effectiveness against COVID-19-associated emergency visits and hospitalizations, rising to 48% against critical illness requiring intensive care or resulting in death. However, effectiveness varied dramatically by time since vaccination. In the first 7-59 days after vaccination, protection reached 49-51% for milder outcomes and 68% for critical illness. By 180-299 days post-vaccination, effectiveness had waned to negative values for emergency visits and hospitalizations, though some protection against critical illness persisted.

These findings have important implications for vaccination policy and individual decision-making. The data support current recommendations for annual COVID-19 vaccination, particularly given the substantial waning of protection over time. The stronger and more durable protection against severe outcomes reinforces vaccination's primary value in preventing the most serious consequences of COVID-19, especially for older adults and those at higher risk.

Important limitations include the observational study design, potential unmeasured confounding factors, and the focus on medically-attended illness rather than all infections. The negative effectiveness observed at longer intervals may reflect behavioral differences between vaccinated and unvaccinated individuals rather than true vaccine failure.